By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 120.19 |
| Change Today | $ -3.21 |
| % Change | -2.60 % |
| 52 Week High | $124.08 |
| 52 Week Low | $87.75 |
| Volume | 3,483,887 |
| Shares Issued | 1,246.00m |
| Market Cap | $149,757m |
| RiskGrade | 120 |
| Strong Buy | 9 |
| Buy | 12 |
| Neutral | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 28 |

| Time | Volume / Share Price |
| 12:19 | 100 @ $120.19 |
| 12:19 | 100 @ $120.19 |
| 12:19 | 100 @ $120.17 |
| 12:19 | 100 @ $120.17 |
| 12:19 | 100 @ $120.17 |
You are here: research